Retinal implants have gained increasing interest since it was demonstrated in acute trials that completely blind subjects do have light perception upon electrical stimulation of the inner surface ...

With a U.S. green light for its encapsulated cell therapy technology in the bag, privately held biotech Neurotech ...

Vivani Medical, Inc. (NASDAQ:VANI) said it intends to spin off Cortigent, Inc., a division that develops brain implant ...

The implant was also shown to be safe and well ... Charles Wykoff, director of research at Retinal Consultants of Texas and an investigator in the Encelto clinical trials, said in Neurotech ...

ILUVIEN now approved for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye (NIU-PS) ...

The US Food and Drug Administration (FDA) has approved Encelto (revakinagene taroretcel-lwey) for the treatment of macular ...

The Food and Drug Administration (FDA) has approved Encelto (revakinagene taroretcel-lwey) for the treatment of macular telangiectasia type 2 (MacTel).

The global Dental Implants and Prosthetics Market, valued at US$11.61 billion in 2024, is forecasted to grow at a robust CAGR of 8.4%, reaching US$12.57 billion in 2025 and an impressive US$18.79 ...

BCI technology is no longer just a science fiction plot, and legislators will have to decide how to ensure people’s private ...

Fintel reports that on March 11, 2025, Needham initiated coverage of Ocular Therapeutix (NasdaqGM:OCUL) with a Buy ...

A bill from state Sen. Tom Umberg seeks to ensure companies collecting such information use it only for the purpose for which ...